tetradecanoylphorbol acetate has been researched along with Cystadenocarcinoma, Serous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eastman, A; Hom, DK; Howell, SB; Isonishi, S | 1 |
| Peng, Z; Wei, Y; Zhao, X | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Cystadenocarcinoma, Serous
| Article | Year |
|---|---|
Enhancement of sensitivity to platinum(II)-containing drugs by 12-O-tetradecanoyl-phorbol-13-acetate in a human ovarian carcinoma cell line.
Topics: Carboplatin; Cisplatin; Cystadenocarcinoma, Serous; DNA, Neoplasm; Drug Synergism; Enzyme Activation; Female; Glutathione; Glutathione Transferase; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Protein Kinase C; Pyrazoles; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1994 |
[Phorbol-12-myristate-13-acetate and interferon-gamma synergistic induction of B7-1 expression in ovary carcinoma cells and immunological value].
Topics: B7-1 Antigen; Cell Transformation, Neoplastic; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Drug Synergism; Female; Humans; Interferon-gamma; Ovarian Neoplasms; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1999 |